Key Steps Toward Using Artificial Intelligence in Pharmacovigilance – Sidley Insights on the Recent CIOMS Draft Report

The Council for International Organizations of Medical Sciences Working Group XIV (CIOMS) has produced a draft report (the Draft Report) on the use of artificial intelligence (AI) in pharmacovigilance (PV). Torrey Cope, Anna Melin, and Andrew James provide insights on how life sciences companies can take steps to implement key concepts from the Draft Report.

It Is Now More Difficult For International Pharma To Transfer Data Out Of China

New measures for the security assessment of data transfers from China to other countries could make it harder for international pharma companies with China operations to transfer health data out of the country. Lianying Wang explains.

If Your Company Is GDPR Compliant, Are You Ready for China’s PIPL?

China’s first dedicated law on personal data protection comes into effect this month. Sidley counsel Jing Lu looks at how the new Personal Information Protection Law (PIPL) differs from Europe’s General Data Protection Regulation (GDPR).

(more…)